PRODUCTS

The unique chemistry underlying Cohera’s technology serves as a platform from which multiple products can be developed.  Small changes in the chemical formulation can lead to product line extensions for a variety of surgical indications, including soft tissue fixation, mesh fixation, and small bone approximation.  Because our adhesive is created from benign ingredients, its break-down products are designed to be non-toxic, with virtually no foreign nody reaction or inflammation based on preliminary testing in animals.

Our lead product under development, TissuGlu®, is a deep wound adhesive for securing planar flaps of tissue to reduce fluid accumulation in the wound.

We are also developing a fast, strong adhesive for securing soft tissues and implantable devices such as hernia mesh.

Our bone adhesive will be targeted at fixation of small bones, where hardware solutions are unmanageable.

Disclaimer: The products presented in this website are not currently available for sale or distribution and have not been approved by the U.S. FDA or other regulatory authority. The devices described within this site are currently limited to investigational use only.